4 Companies Up Big in 2014: Are They Flying Under Your Radar?

These REITs are clearly outperforming the S&P 500 and deserve a closer look.

Feb 12, 2014 at 7:00AM

After a banner 2013, the overall market has had a challenging start to 2014. However, these four companies have been crushing it: Alexander Real Estate (NYSE:ARE), BioMed Realty Trust (NYSE:BMR), CommonWealth REIT (NYSE:EQC), and Sun Communities (NYSE:SUI) early on in 2014 vs. the S&P 500. Their relative out-performance can also be seen when compared to the Vanguard REIT Index ETF (NYSEMKT:VNQ) a good yardstick to measure sector performance.

^SPXTR Chart

Why CommonWealth stock may have popped
Current management finds itself under siege by activist shareholders seeking to replace the entire board of directors. CommonWealth REIT is externally managed, and two large shareholders feel current management interests are not aligned with common shareholders. This evolving situation explains the stellar performance of CommonWealth shares year to date.

CommonWealth is an office REIT with a $3 billion market cap. The company pays shareholders a quarterly dividend of $0.25, which yields 3.86% annually based on the $25.91 share price at close of market Feb. 6, 2014.

The stock has had a huge run up so far this year, and at current price levels, it does not appear to be much of a bargain for new investors. It might be wise to let the dust settle and see which direction the winning management group will lead the company moving forward.

What's new under the sun?
Sun Communities is a $1.72 billion market cap REIT that owns 190 manufactured home and recreation vehicle, or RV, communities totaling 69,800 developed sites. Sun primarily makes money renting the sites to homeowners and RV tenants, as well as generating revenue from home sales. On Jan. 7, 2014, Wells Fargo upgraded the manufactured housing REIT sector to Overweight, and upgraded Sun Communities to Outperform citing positive home sales trends.

More positive news from Sun Communities came on Jan. 23rd when the company provided 2014 guidance, including:

  • A target $0.08 increase in distribution per common share
  • A midrange estimate of funds from operations, or FFO, per share increase of 11.23% over 2013 FFO
  • Average annual rent increases of 3.2%

In general, guidance was upbeat, and the relative stock outperformance seems to reflect the positive news. Sun will host an earnings call on Feb. 20, 2014 to discuss the quarter ending December and full year results for 2013. Sun common stock is currently yielding an attractive 5.3%, even after the recent increases in the stock.

The Life Sciences REIT sector is growing
Alexandria and BioMed, with market caps of $5 billion and $3.8 billion, respectively, are the two main players when it comes to developing and owning laboratory/office assets.

These facilities are typically utilized by science research institutions, biotech, pharma, government agencies, and related industries. The complex needs of this client base provides a competitive moat for these two specialty REITs.

Each recently reported strong leasing activity and significant acquisitions. In addition, financial metrics appeared to be strong both companies. Based upon the conference calls future growth drivers for the life science sector include:

  • 46 U.S. biotech companies priced IPOs in 2013, the most in 13 years
  • 59% of all FDA drug approvals in 2013 were by Alexander clients
  • BioMed in 2013 had the best leasing year in company history including 34 new tenant relationships

Investors should be aware these companies own land and are active in developing complex build-to-suit solutions for clients -- so in any given quarter, future earnings could be a bit lumpy. Interested investors should review the detailed 2013 financial and operating results available in the companies' filings. But here is some back-of-the-envelope math to ponder:

Based upon the mid-range FFO guidance of $4.70 per share and a stock price of $71.08, Alexander is currently trading at 15 times FFO for 2014 -- with a dividend yield of 3.83%.

For BioMed, based upon mid-range FFO guidance of $1.42 per share the stock price of $19.79 indicates it is trading at 14 times FFO. BioMed is currently paying a dividend yielding 5.05%.

Investor takeaway
Value investors may be attracted to BioMed over Alexander in the short-term based upon valuation and yield. However, life science appears to be a growth story, so investors need to do some homework regarding which REIT is more likely to provide accretive growth moving forward. Of course, you could also invest in both of them if you believe that growth in life science will continue to accelerate.

Sun Communities also appears to have good visibility for growth opportunities and pays a competitive 5.3% dividend. CommonWealth REIT stock appreciation appears to be more speculative, so long-term investors should be cautious regarding this high-flyer in the office REIT sector.

2 more earth-shattering biotech revolutions
The best way to play the biotech space is to find companies that shun the status quo and instead discover revolutionary, groundbreaking technologies. In the Motley Fool's brand-new FREE report "2 Game-Changing Biotechs Revolutionizing the Way We Treat Cancer," find out about a new technology that big pharma is endorsing through partnerships, and the two companies that are set to profit from this emerging drug class. Click here to get your copy today.

Bill Stoller has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

1 Key Step to Get Rich

Our mission at The Motley Fool is to help the world invest better. Whether that’s helping people overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we can help.

Feb 1, 2016 at 4:54PM

To be perfectly clear, this is not a get-rich action that my Foolish colleagues and I came up with. But we wouldn't argue with the approach.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich" rated The Motley Fool as the #1 place online to get smarter about investing.

"The Motley Fool aims to build a strong investment community, which it does by providing a variety of resources: the website, books, a newspaper column, a radio [show], and [newsletters]," wrote (the clearly insightful and talented) money reporter Kathleen Elkins. "This site has something for every type of investor, from basic lessons for beginners to investing commentary on mutual funds, stock sectors, and value for the more advanced."

Our mission at The Motley Fool is to help the world invest better, so it's nice to receive that kind of recognition. It lets us know we're doing our job.

Whether that's helping the entirely uninitiated overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we want to provide our readers with a boost to the next step on their journey to financial independence.

Articles and beyond

As Business Insider wrote, there are a number of resources available from the Fool for investors of all levels and styles.

In addition to the dozens of free articles we publish every day on our website, I want to highlight two must-see spots in your tour of fool.com.

For the beginning investor

Investing can seem like a Big Deal to those who have yet to buy their first stock. Many investment professionals try to infuse the conversation with jargon in order to deter individual investors from tackling it on their own (and to justify their often sky-high fees).

But the individual investor can beat the market. The real secret to investing is that it doesn't take tons of money, endless hours, or super-secret formulas that only experts possess.

That's why we created a best-selling guide that walks investors-to-be through everything they need to know to get started. And because we're so dedicated to our mission, we've made that available for free.

If you're just starting out (or want to help out someone who is), go to www.fool.com/beginners, drop in your email address, and you'll be able to instantly access the quick-read guide ... for free.

For the listener

Whether it's on the stationary exercise bike or during my daily commute, I spend a lot of time going nowhere. But I've found a way to make that time benefit me.

The Motley Fool offers five podcasts that I refer to as "binge-worthy financial information."

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. It's also featured on several dozen radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable ... and I don't say that simply because the hosts all sit within a Nerf-gun shot of my desk. Rule Breaker Investing and Answers contain timeless advice, so you might want to go back to the beginning with those. The other three take their cues from the market, so you'll want to listen to the most recent first. All are available at www.fool.com/podcasts.

But wait, there's more

The book and the podcasts – both free ... both awesome – also come with an ongoing benefit. If you download the book, or if you enter your email address in the magical box at the podcasts page, you'll get ongoing market coverage sent straight to your inbox.

Investor Insights is valuable and enjoyable coverage of everything from macroeconomic events to investing strategies to our analyst's travels around the world to find the next big thing. Also free.

Get the book. Listen to a podcast. Sign up for Investor Insights. I'm not saying that any of those things will make you rich ... but Business Insider seems to think so.

Compare Brokers